Illumina has launched a nonexclusive partnership with Emedgene, an artificial intelligence-based precision medicine company, to integrate automated interpretation of rare genetic disease data into ...
PALO ALTO, California, Dec. 16, 2020 /PRNewswire/ -- Emedgene, a leading precision medicine intelligence company, announces a non-exclusive partnership with Illumina Inc. and the integration of ...
With genetics research marching forward, keeping up with all the new discoveries in the field can be a challenge for geneticists—and investors are betting startup Emedgene has a solution. Emedgene has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results